176 related articles for article (PubMed ID: 23188736)
1. Direct-acting antiviral agents for the treatment of HCV.
Thompson AJ; Locarnini S
Antivir Ther; 2012; 17(6 Pt B):1105-7. PubMed ID: 23188736
[No Abstract] [Full Text] [Related]
2. Antiviral resistance and direct-acting antiviral agents for HCV.
Aloia AL; Locarnini S; Beard MR
Antivir Ther; 2012; 17(6 Pt B):1147-62. PubMed ID: 23188771
[TBL] [Abstract][Full Text] [Related]
3. Are we nearing the end in the fight against hepatitis C?
Chua JV; Kottilil S
Expert Rev Gastroenterol Hepatol; 2017 Jun; 11(6):499-500. PubMed ID: 28335650
[No Abstract] [Full Text] [Related]
4. Hepatitis C virus virology and new treatment targets.
Meier V; Ramadori G
Expert Rev Anti Infect Ther; 2009 Apr; 7(3):329-50. PubMed ID: 19344246
[TBL] [Abstract][Full Text] [Related]
5. [Selection of direct-acting antiviral agents for chronic hepatitis C infection].
He YJ; Liu ZH; Hou JL
Zhonghua Gan Zang Bing Za Zhi; 2018 Mar; 26(3):169-172. PubMed ID: 29804388
[TBL] [Abstract][Full Text] [Related]
6. Highly active anti-hepatitis C therapy: seven lessons from HIV.
Thomas DL
Antivir Ther; 2012; 17(6 Pt B):1183-8. PubMed ID: 23186629
[TBL] [Abstract][Full Text] [Related]
7. [Antiviral treatment of chronic hepatitis C].
Berger A
Med Monatsschr Pharm; 2012 Feb; 35(2):55-60. PubMed ID: 22400430
[TBL] [Abstract][Full Text] [Related]
8. Directly acting antivirals against hepatitis C virus.
Soriano V; Vispo E; Poveda E; Labarga P; Martin-Carbonero L; Fernandez-Montero JV; Barreiro P
J Antimicrob Chemother; 2011 Aug; 66(8):1673-86. PubMed ID: 21652618
[TBL] [Abstract][Full Text] [Related]
9. HCV's days are numbered: next-generation direct-acting antivirals and host-targeting agents.
Calle Serrano B; Manns MP
Antivir Ther; 2012; 17(6 Pt B):1133-46. PubMed ID: 23188760
[TBL] [Abstract][Full Text] [Related]
10. The remaining challenges of HCV treatment in the direct-acting antivirals era.
Kim BK; Ahn SH
J Gastroenterol Hepatol; 2019 Nov; 34(11):1891-1892. PubMed ID: 31724229
[No Abstract] [Full Text] [Related]
11. Future treatment of chronic hepatitis C with direct acting antivirals: is resistance important?
Halfon P; Sarrazin C
Liver Int; 2012 Feb; 32 Suppl 1():79-87. PubMed ID: 22212577
[TBL] [Abstract][Full Text] [Related]
12. New direct-acting antiviral agents for the treatment of hepatitis C virus infection and perspectives.
Welsch C; Jesudian A; Zeuzem S; Jacobson I
Gut; 2012 May; 61 Suppl 1():i36-46. PubMed ID: 22504918
[TBL] [Abstract][Full Text] [Related]
13. Is there a role for ribavirin in the era of hepatitis C virus direct-acting antivirals?
Feld JJ
Gastroenterology; 2012 May; 142(6):1356-9. PubMed ID: 22537443
[No Abstract] [Full Text] [Related]
14. Future directions in therapy for chronic hepatitis C.
Jensen DM; Ascione A
Antivir Ther; 2008; 13 Suppl 1():31-6. PubMed ID: 18432161
[TBL] [Abstract][Full Text] [Related]
15. The science of direct-acting antiviral and host-targeted agent therapy.
Pawlotsky JM
Antivir Ther; 2012; 17(6 Pt B):1109-17. PubMed ID: 23188746
[TBL] [Abstract][Full Text] [Related]
16. Hepatitis C and arthritis: an update.
Sanzone AM; Bégué RE
Infect Dis Clin North Am; 2006 Dec; 20(4):877-89, vii. PubMed ID: 17118294
[TBL] [Abstract][Full Text] [Related]
17. Lack of full CD8 functional restoration after antiviral treatment for acute and chronic hepatitis C virus infection.
Missale G; Pilli M; Zerbini A; Penna A; Ravanetti L; Barili V; Orlandini A; Molinari A; Fasano M; Santantonio T; Ferrari C
Gut; 2012 Jul; 61(7):1076-84. PubMed ID: 22337949
[TBL] [Abstract][Full Text] [Related]
18. How to use virological tools for the optimal management of chronic hepatitis C.
de Leuw P; Sarrazin C; Zeuzem S
Liver Int; 2011 Jan; 31 Suppl 1():3-12. PubMed ID: 21205131
[TBL] [Abstract][Full Text] [Related]
19. Future of hepatitis C therapy: development of direct-acting antivirals.
Dore GJ; Matthews GV; Rockstroh J
Curr Opin HIV AIDS; 2011 Nov; 6(6):508-13. PubMed ID: 21897228
[TBL] [Abstract][Full Text] [Related]
20. HCV core gene polymorphisms correlate with liver fibrosis but not sustained virological response in patients with genotype 1 infection.
Hsu SJ; Hsu CS; Liu CH; Liu CJ; Chen CL; Chen PJ; Chen DS; Kao JH
Antivir Ther; 2011; 16(2):227-35. PubMed ID: 21447872
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]